• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Amazon, Starbucks, Home Depot in the Hot Seat As Boycotts Heat Up

July 2, 2025

Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July

July 2, 2025

10 Budgeting Rules That Are Quietly Hurting Middle-Class Families

July 2, 2025
Facebook Twitter Instagram
Trending
  • Amazon, Starbucks, Home Depot in the Hot Seat As Boycotts Heat Up
  • Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July
  • 10 Budgeting Rules That Are Quietly Hurting Middle-Class Families
  • How One Founder Is Rethinking Supplements With David Beckham
  • Why Your Finance Team Needs an AI Strategy, Now
  • AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000
  • He Went From $471K in Debt to Teaching Others How to Succeed
  • Summer Financial Checklist
Wednesday, July 2
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » US FDA approves Biogen-Sage Therapeutics pill for postpartum depression
Investing

US FDA approves Biogen-Sage Therapeutics pill for postpartum depression

News RoomBy News RoomAugust 5, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

© Reuters

(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics’ oral pill to treat postpartum depression (PPD (NASDAQ:)) in adults.

The companies had sought the FDA’s approval for the drug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of people.

PPD severely affects a woman’s ability to return to normal functioning, while also potentially affecting the mother’s relationship with her child.

“Zurzuvae is expected to launch and be commercially available in the fourth quarter of 2023 shortly following scheduling as a controlled substance by the U.S. Drug Enforcement Administration, which is anticipated to occur within 90 days,” Sage Therapeutics and Biogen said in a statement.

The statement said the FDA issued a Complete Response Letter for the New Drug Application for Zurzuvae in the treatment of adults with MDD. The letter said the application did not provide substantial evidence of the effectiveness of Zurzuvae for treating of MDD and that additional studies would be needed to support the approval.

Sage and Biogen said they were reviewing the feedback and evaluating next steps.

Analysts have anticipated that the stocks of both companies would fall if the drug was approved only for postpartum depression, due to the smaller patient population.

Until now, the FDA said, treatment for postpartum depression was available only as an intravenous injection.

In 2021, an estimated 21 million adults in the United States had at least one episode of major depressive disorder, which is characterized by a persistent feeling of sadness. PPD affects around one in seven women who give birth.

Read the full article here

Featured
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Amazon, Starbucks, Home Depot in the Hot Seat As Boycotts Heat Up

Burrow July 2, 2025

Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July

Make Money July 2, 2025

10 Budgeting Rules That Are Quietly Hurting Middle-Class Families

Budgeting July 2, 2025

How One Founder Is Rethinking Supplements With David Beckham

Make Money July 1, 2025

Why Your Finance Team Needs an AI Strategy, Now

Investing July 1, 2025

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000

Make Money July 1, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July

July 2, 20250 Views

10 Budgeting Rules That Are Quietly Hurting Middle-Class Families

July 2, 20250 Views

How One Founder Is Rethinking Supplements With David Beckham

July 1, 20250 Views

Why Your Finance Team Needs an AI Strategy, Now

July 1, 20250 Views
Don't Miss

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000

By News RoomJuly 1, 2025

The $10 billion AI startup Thinking Machines Lab (TML), which was founded by former OpenAI…

He Went From $471K in Debt to Teaching Others How to Succeed

July 1, 2025

Summer Financial Checklist

July 1, 2025

3 Gently Used Cars You Can Still Buy for Under $20,000

July 1, 2025
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.